In April 2025, the U.S. Food and Drug Administration (FDA) announced a groundbreaking initiative to phase out the animal testing requirement for monoclonal antibodies and other drugs. This marked a significant milestone in the advancement of preclinical research. Experts from regulatory agencies, academia, and industry worldwide convened to promote the adoption of New Approach Methodologies […]
TheWell Bioscience Unveils VitroGel® NEURON: A Breakthrough in 3D and 2D Neuron Culture TheWell Bioscience proudly launches VitroGel® NEURON, a ready-to-use, xeno-free hydrogel system designed to support both 2D and 3D cultures of neural stem cells and neurons. This innovative product aims to provide researchers with an animal-free, reliable, and consistent platform for neural cell […]
We are excited to announce that TheWell Bioscience will be exhibiting at the ISSCR 2025 Annual Meeting—the premier global event for stem cell and regenerative medicine research. Join us and thousands of scientists, clinicians, and industry leaders as we explore the cutting edge of stem cell science and shape the future of biomedical innovation. Discover […]
